NCT01760460View on ClinicalTrials.gov

A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1)

PHASE3CompletedINTERVENTIONAL
Enrollment

307

Participants

Timeline

Start Date

March 14, 2013

Primary Completion Date

March 4, 2015

Study Completion Date

March 4, 2015

Conditions
Dyslipidemia
Interventions
DRUG

Anacetrapib

DRUG

Placebo for anacetrapib

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT01760460 - A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Dyslipidemia (MK-0859-051 AM1) | Biotech Hunter | Biotech Hunter